Literature DB >> 16918199

Central nervous system involvement in HCV-related mixed cryoglobulinemia.

A Cappellari1, L Origgi, M F Spina, K G Yiannopoulou, G Meola, M Vanoli, A Ciammola, F Gregorini, R Scorza, N Bresolin.   

Abstract

An involvement of the peripheral nervous system is frequent in patients with HCV-related mixed cryoglobulinemia (HCV-MC), whereas central nervous system (CNS) impairment has been rarely reported. To investigate the possible CNS involvement in MC, we evaluated 18 patients by neurophysiological, neuroradiological and neuropsychological methods. Three patients (16.7%) had clinically evident neurological central signs, ten (55.5%) complained of mild symptoms, possibly indicative of CNS impairment, and five (27.8%) did not have any CNS symptom. Evoked potentials (EPs) were abnormal in 83% of the cases (SSEPs in 72%, VEPs in 44%, MEPs in 39% and BAERs in 22%). Brain magnetic resonance imaging (MRI) showed abnormal findings in 83% (small T2-weighted hyperintense lesions in 72%, focal or diffuse atrophy in 50%). Cognitive impairment was detected in 22% of the patients. A mild or subclinical CNS involvement is frequent in MC patients. Neuropsychological, neurophysiological and neuroradiological examination are useful to detect CNS involvement also in asymptomatic subjects.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16918199

Source DB:  PubMed          Journal:  Electromyogr Clin Neurophysiol        ISSN: 0301-150X


  3 in total

1.  Is there a direct role of hepatitis C virus in portosystemic encephalopathy?

Authors:  Giovanni Tarantino
Journal:  J Gastroenterol       Date:  2008-03-29       Impact factor: 7.527

2.  Screening for Electrophysiological Abnormalities in Chronic Hepatitis C Infection: Peripheral Neuropathy and Optic Neuropathy.

Authors:  Aslı Köşkderelioğlu; Pınar Ortan; Alpay Ari; Muhteşem Gedizlioğlu
Journal:  Noro Psikiyatr Ars       Date:  2016-03-01       Impact factor: 1.339

3.  Pharmacokinetics of the antiviral agent beta-D-2'-deoxy-2'-fluoro-2'-C-methylcytidine in rhesus monkeys.

Authors:  Ghazia Asif; Selwyn J Hurwitz; Junxing Shi; Brenda I Hernandez-Santiago; Raymond F Schinazi
Journal:  Antimicrob Agents Chemother       Date:  2007-06-11       Impact factor: 5.191

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.